OXM- IgG4Fc fusion protein (Transira Therapeutics)

N/A

Report date: 2025/03/20 09:13:20

Base Information

Drug NameOXM- IgG4Fc fusion protein (Transira Therapeutics)
Drug Alias NameGLP-1R/GCGR agonist oxyntomodulin-Fc (Transira Therapeutics)oxyntomodulin-Fc fusion protein
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransira Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesTransira Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A